Cara Therapeutics (CARA)
(Delayed Data from NSDQ)
$0.28 USD
+0.03 (12.33%)
Updated Jun 21, 2024 04:00 PM ET
After-Market: $0.28 0.00 (1.08%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Earnings News For CARA
-
Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
-
Cara: Q1 Earnings Snapshot
-
Cara Therapeutics Reports First Quarter 2024 Financial Results
-
Cara: Q4 Earnings Snapshot
-
Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates
-
Cara: Q3 Earnings Snapshot
-
Cara Therapeutics Reports Third Quarter 2023 Financial Results
-
Earnings Preview: Cara Therapeutics (CARA) Q3 Earnings Expected to Decline
-
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
-
Cara: Q2 Earnings Snapshot
-
Cara Therapeutics Reports Second Quarter 2023 Financial Results
-
Cara Therapeutics (CARA) Reports Q1 Loss, Tops Revenue Estimates
-
Cara: Q1 Earnings Snapshot
-
Cara Therapeutics Reports First Quarter 2023 Financial Results
-
Cara: Q4 Earnings Snapshot
-
Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates
-
Will Cara Therapeutics (CARA) Report Negative Earnings Next Week? What You Should Know
-
Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates
-
Cara: Q3 Earnings Snapshot
-
Cara Therapeutics Reports Third Quarter 2022 Financial Results
-
Cara Therapeutics (CARA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
-
Cara: Q2 Earnings Snapshot
-
Cara Therapeutics Reports Second Quarter 2022 Financial Results
-
Cara Therapeutics (CARA) Reports Q1 Loss, Lags Revenue Estimates